Poultry Vaccines Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powder Form Vaccines), Disease [Avian Influenza, Avian Salmonellosis, Marek's Disease, Infectious Bronchitis, Infectious Bursal Disease (IBD), Newcastle Disease, and Others], Route of Administration [Drinking Water (D/W), Intramuscular (I/M), Subcutaneous (I/S), and Others], End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers & Clinics), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
The poultry vaccines market size is projected to grow from US$ 2.1 billion in 2023 to US$ 4.1 billion by 2031; the market is estimated to record a CAGR of 8.6% during 2021–2031. The rising prevalence of poultry diseases are the key factors and advancements in vectored and combination vaccines propelling the poultry vaccines market development. However, product recall hamper the poultry vaccines market growth. Furthermore, the advancements in vectored and combination vaccines are likely to remain key poultry vaccines market trends during 2021-2031.
Growth Drivers:
Rising Prevalence of Poultry Diseases Drives Market Growth
Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as “Fowl disease” that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle disease, avian influenza, infectious bursal disease, and other diseases to wide range of poultry animals.
The table below provides disease outbreaks of avian influenza among mammals across several countries in 2022.
Cases of Avian Influenza in Mammals
Country Poultry Diseases Disease Outbreak (2022)
Argentina H5 18
Chile 34
Norway 2
Uruguay 3
Peru 12
Brazil H5N1 5
Canada 40
China 1
Estonia 1
Finland 76
France 2
Ireland 2
Italy 3
Japan 4
Russia 1
Canada H5N5 2
Denmark H5N8 1
Source: World Organization for Animal Health 2023
Poultry diseases are a major cause of death of chicks and also lead to reduced livestock. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products. The International Journal of Current Microbiology and Applied Sciences (IJCMAS) report published in October 2021 reveals that total losses due to Newcastle disease mortality and total expenditure on live birds in all the 25 commercial broiler farms ranged between INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. Also, the selling income of live birds from individual farms ranged from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infection.
Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.
Report Segmentation and Scope:
• The poultry vaccines market is segmented into type, technology, dosage form, disease, route of administration, and end user. Based on type, the poultry vaccines market is divided into broiler and layer. The broiler segment held a larger market share in 2023.
• By technology, the market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share of the market in 2023.
• In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023.
• In terms of disease, the market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment dominated the market in 2023.
• In terms of route of administration, the market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment dominated the market in 2023.
• In terms of end user, the market is segmented into poultry farms, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms segment dominated the market in 2023.
Type-Based Insights
By type, the poultry vaccines market is bifurcated into broiler and layer. The broiler segment held the largest market share of the poultry vaccines market in 2023. Broilers are young chickens of six to eight weeks of age with 1.5–2.0 kg average body weight, flexible breastbone cartilage, and pliable and soft meat. They are bred and raised for meat production. The majority of commercial broilers achieve slaughter weight between four and seven weeks of age. Due to intense breeding selection for rapid early growth, broiler breeds are highly vulnerable to skeletal deformity, skin & eye diseases, and congestive heart disorders. To ensure the well-being of the flock, ventilation, housing, stocking density, and in-house operations are examined on a regular basis. As the males grow faster than females, they need higher floor space and nutrients than female broilers. Hence, male and female broiler chicks are reared separately in many countries.
Vaccination programs are one of the essential tools for disease and viral disease prevention, especially for broilers in poultry farming. Vaccines contain the attenuated pathogen or at low concentrations that cause a mild infection or antigenic components of the microorganism, which will make the broiler immune from particular diseases. Vaccines for Marek’s disease are given at the hatchery at day one age of broiler by subcutaneous route of administration. Therefore, broiler segment bolster the poultry vaccines market growth during the forecast period.
Regional Analysis:
The geographic scope of the poultry vaccines market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.
Asia Pacific has dominated the poultry vaccines market and is anticipated to grow with the highest CAGR in the coming years. In Asia Pacific, China accounted for the largest share of the poultry vaccines market in 2023. China is witnessing rapid economic growth and urbanization. China has one of the major healthcare systems in the region. The market growth in the country can be accredited to the growing demand for poultry meat, the increasing consumption of animal-derived food products, the growing livestock population, increasing awareness about animal health, and the rising frequency of poultry disease outbreaks in China. Therefore, favorable government initiatives to promote vaccination among the population of China are the key factor influencing the poultry vaccines market growth.
Growth Drivers:
Rising Prevalence of Poultry Diseases Drives Market Growth
Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as “Fowl disease” that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle disease, avian influenza, infectious bursal disease, and other diseases to wide range of poultry animals.
The table below provides disease outbreaks of avian influenza among mammals across several countries in 2022.
Cases of Avian Influenza in Mammals
Country Poultry Diseases Disease Outbreak (2022)
Argentina H5 18
Chile 34
Norway 2
Uruguay 3
Peru 12
Brazil H5N1 5
Canada 40
China 1
Estonia 1
Finland 76
France 2
Ireland 2
Italy 3
Japan 4
Russia 1
Canada H5N5 2
Denmark H5N8 1
Source: World Organization for Animal Health 2023
Poultry diseases are a major cause of death of chicks and also lead to reduced livestock. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products. The International Journal of Current Microbiology and Applied Sciences (IJCMAS) report published in October 2021 reveals that total losses due to Newcastle disease mortality and total expenditure on live birds in all the 25 commercial broiler farms ranged between INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. Also, the selling income of live birds from individual farms ranged from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infection.
Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.
Report Segmentation and Scope:
• The poultry vaccines market is segmented into type, technology, dosage form, disease, route of administration, and end user. Based on type, the poultry vaccines market is divided into broiler and layer. The broiler segment held a larger market share in 2023.
• By technology, the market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share of the market in 2023.
• In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023.
• In terms of disease, the market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment dominated the market in 2023.
• In terms of route of administration, the market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment dominated the market in 2023.
• In terms of end user, the market is segmented into poultry farms, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms segment dominated the market in 2023.
Type-Based Insights
By type, the poultry vaccines market is bifurcated into broiler and layer. The broiler segment held the largest market share of the poultry vaccines market in 2023. Broilers are young chickens of six to eight weeks of age with 1.5–2.0 kg average body weight, flexible breastbone cartilage, and pliable and soft meat. They are bred and raised for meat production. The majority of commercial broilers achieve slaughter weight between four and seven weeks of age. Due to intense breeding selection for rapid early growth, broiler breeds are highly vulnerable to skeletal deformity, skin & eye diseases, and congestive heart disorders. To ensure the well-being of the flock, ventilation, housing, stocking density, and in-house operations are examined on a regular basis. As the males grow faster than females, they need higher floor space and nutrients than female broilers. Hence, male and female broiler chicks are reared separately in many countries.
Vaccination programs are one of the essential tools for disease and viral disease prevention, especially for broilers in poultry farming. Vaccines contain the attenuated pathogen or at low concentrations that cause a mild infection or antigenic components of the microorganism, which will make the broiler immune from particular diseases. Vaccines for Marek’s disease are given at the hatchery at day one age of broiler by subcutaneous route of administration. Therefore, broiler segment bolster the poultry vaccines market growth during the forecast period.
Regional Analysis:
The geographic scope of the poultry vaccines market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.
Asia Pacific has dominated the poultry vaccines market and is anticipated to grow with the highest CAGR in the coming years. In Asia Pacific, China accounted for the largest share of the poultry vaccines market in 2023. China is witnessing rapid economic growth and urbanization. China has one of the major healthcare systems in the region. The market growth in the country can be accredited to the growing demand for poultry meat, the increasing consumption of animal-derived food products, the growing livestock population, increasing awareness about animal health, and the rising frequency of poultry disease outbreaks in China. Therefore, favorable government initiatives to promote vaccination among the population of China are the key factor influencing the poultry vaccines market growth.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
4. POULTRY VACCINES MARKET LANDSCAPE
4.1 PEST Analysis
5. POULTRY VACCINES MARKET – KEY MARKET DYNAMICS
5.1 Poultry Vaccines Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Poultry Diseases
5.2.2 Growing Poultry Industry
5.3 Market Restraints
5.3.1 Vaccination Failure and Improper Handling
5.4 Market Opportunities
5.4.1 Government Support for Mass Vaccination Drives and Innovative Schemes
5.5 Future Trends
5.5.1 Advancements in Vectored and Combination Vaccines
5.6 Impact of Drivers and Restraints:
6. POULTRY VACCINES MARKET ANALYSIS
6.1 Poultry Vaccines Market Revenue (US$ Million), 2023–2031
7. POULTRY VACCINES MARKET ANALYSIS – BY TYPE
7.1 Overview
7.2 Broiler
7.2.1 Overview
7.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Layer
7.3.1 Overview
7.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. POULTRY VACCINES MARKET ANALYSIS – BY TECHNOLOGY
8.1 Overview
8.2 Live Attenuated Vaccines
8.2.1 Overview
8.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Inactivated Vaccines
8.3.1 Overview
8.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Recombinant Vaccines
8.4.1 Overview
8.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. POULTRY VACCINES MARKET ANALYSIS – BY DOSAGE FORM
9.1 Overview
9.2 Liquid Vaccines
9.2.1 Overview
9.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Freeze-Dried Vaccines
9.3.1 Overview
9.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Dust/Powdered Vaccines
9.4.1 Overview
9.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. POULTRY VACCINES MARKET ANALYSIS – BY DISEASE
10.1 Overview
10.2 Avian Influenza
10.2.1 Overview
10.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Salmonellosis
10.3.1 Overview
10.3.2 Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Mareks Disease
10.4.1 Overview
10.4.2 Mareks Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Infectious Bronchitis (IB)
10.5.1 Overview
10.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Infectious Bursal Disease (IBD)
10.6.1 Overview
10.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.7 Newcastle Disease
10.7.1 Overview
10.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. POULTRY VACCINES MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
11.1 Overview
11.2 Drinking Water (D/W)
11.2.1 Overview
11.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Intramuscular (I/M)
11.3.1 Overview
11.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Subcutaneous (S/C)
11.4.1 Overview
11.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. POULTRY VACCINES MARKET ANALYSIS – BY END USER
12.1 Overview
12.2 Poultry Farms
12.2.1 Overview
12.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.3 Veterinary Hospitals
12.3.1 Overview
12.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.4 Poultry Vaccination Centers and Clinics
12.4.1 Overview
12.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13. POULTRY VACCINES MARKET – GEOGRAPHICAL ANALYSIS
13.1 North America
13.1.1 North America Poultry Vaccines Market Overview
13.1.2 North America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.1.3.1 United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.1.1 Overview
13.1.3.1.2 United States: Poultry Vaccines Market Breakdown by Type
13.1.3.1.3 United States: Poultry Vaccines Market Breakdown by Technology
13.1.3.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.1.5 United States: Poultry Vaccines Market Breakdown by Disease
13.1.3.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.1.7 United States: Poultry Vaccines Market Breakdown by End User
13.1.3.2 Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.2.1 Overview
13.1.3.2.2 Canada: Poultry Vaccines Market Breakdown by Type
13.1.3.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
13.1.3.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
13.1.3.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.2.7 Canada: Poultry Vaccines Market Breakdown by End User
13.1.3.3 Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.3.1 Overview
13.1.3.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
13.1.3.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
13.1.3.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
13.1.3.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
13.2 Europe
13.2.1 Europe Poultry Vaccine Market Overview
13.2.2 Europe: Poultry Vaccine Market – Revenue and Forecast to 2031 (US$ Million)
13.2.3 Poultry Vaccines Market Breakdown by Countries
13.2.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.2.4.1 Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.1.1 Overview
13.2.4.1.2 Germany: Poultry Vaccines Market Breakdown by Type
13.2.4.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
13.2.4.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
13.2.4.1.6 Germany: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.1.7 Germany: Poultry Vaccines Market Breakdown by End User
13.2.4.2 Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.2.1 Overview
13.2.4.2.2 Spain: Poultry Vaccines Market Breakdown by Type
13.2.4.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
13.2.4.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
13.2.4.2.6 Spain: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.2.7 Spain: Poultry Vaccines Market Breakdown by End User
13.2.4.3 France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.3.1 Overview
13.2.4.3.2 France: Poultry Vaccines Market Breakdown by Type
13.2.4.3.3 France: Poultry Vaccines Market Breakdown by Technology
13.2.4.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.3.5 France: Poultry Vaccines Market Breakdown by Disease
13.2.4.3.6 France: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.3.7 France: Poultry Vaccines Market Breakdown by End User
13.2.4.4 United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.4.1 Overview
13.2.4.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
13.2.4.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
13.2.4.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
13.2.4.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
13.2.4.5 Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.5.1 Overview
13.2.4.5.2 Italy: Poultry Vaccines Market Breakdown by Type
13.2.4.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
13.2.4.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
13.2.4.5.6 Italy: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.5.7 Italy: Poultry Vaccines Market Breakdown by End User
13.2.4.6 Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.6.1 Overview
13.2.4.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
13.2.4.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
13.2.4.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
13.2.4.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User
13.3 Asia Pacific
13.3.1 Asia Pacific Poultry Vaccines Market Overview
13.3.2 Asia Pacific: Poultry Vaccines Market
13.3.3 Poultry Vaccines Market Breakdown by Countries
13.3.3.1 China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.1.1 Overview
13.3.3.1.2 China: Poultry Vaccines Market Breakdown by Type
13.3.3.1.3 China: Poultry Vaccines Market Breakdown by Technology
13.3.3.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.1.5 China: Poultry Vaccines Market Breakdown by Disease
13.3.3.1.6 China: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.1.7 China: Poultry Vaccines Market Breakdown by End User
13.3.3.2 India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.2.1 Overview
13.3.3.2.2 India: Poultry Vaccines Market Breakdown by Type
13.3.3.2.3 India: Poultry Vaccines Market Breakdown by Technology
13.3.3.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.2.5 India: Poultry Vaccines Market Breakdown by Disease
13.3.3.2.6 India: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.2.7 India: Poultry Vaccines Market Breakdown by End User
13.3.3.3 Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.3.1 Overview
13.3.3.3.2 Japan: Poultry Vaccines Market Breakdown by Type
13.3.3.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
13.3.3.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
13.3.3.3.6 Japan: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.3.7 Japan: Poultry Vaccines Market Breakdown by End User
13.3.3.4 Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.4.1 Overview
13.3.3.4.2 Australia: Poultry Vaccines Market Breakdown by Type
13.3.3.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
13.3.3.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
13.3.3.4.6 Australia: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.4.7 Australia: Poultry Vaccines Market Breakdown by End User
13.3.3.5 South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.5.1 Overview
13.3.3.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
13.3.3.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
13.3.3.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
13.3.3.5.6 South Korea: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
13.3.3.6 Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.6.1 Overview
13.3.3.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
13.3.3.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
13.3.3.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
13.3.3.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User
13.4 Middle East and Africa
13.4.1 Middle East and Africa Poultry Vaccines Market Overview
13.4.2 Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.3 Poultry Vaccines Market Breakdown by Countries
13.4.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.4.4.1 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.1.1 Overview
13.4.4.1.2 The table below represents the H5N8 Avian Influenza (HPAI) outbreak from June 2017 to November 2020:
13.4.4.1.3 South Africa: Poultry Vaccines Market Breakdown by Type
13.4.4.1.4 South Africa: Poultry Vaccines Market Breakdown by Technology
13.4.4.1.5 South Africa: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.1.6 South Africa: Poultry Vaccines Market Breakdown by Disease
13.4.4.1.7 South Africa: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.1.8 South Africa: Poultry Vaccines Market Breakdown by End User
13.4.4.2 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.2.1 Overview
13.4.4.2.2 Saudi Arabia: Poultry Vaccines Market Breakdown by Type
13.4.4.2.3 Saudi Arabia: Poultry Vaccines Market Breakdown by Technology
13.4.4.2.4 Saudi Arabia: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.2.5 Saudi Arabia: Poultry Vaccines Market Breakdown by Disease
13.4.4.2.6 Saudi Arabia: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.2.7 Saudi Arabia: Poultry Vaccines Market Breakdown by End User
13.4.4.3 United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.3.1 Overview
13.4.4.3.2 United Arab Emirates: Poultry Vaccines Market Breakdown by Type
13.4.4.3.3 United Arab Emirates: Poultry Vaccines Market Breakdown by Technology
13.4.4.3.4 United Arab Emirates: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.3.5 United Arab Emirates: Poultry Vaccines Market Breakdown by Disease
13.4.4.3.6 United Arab Emirates: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.3.7 United Arab Emirates: Poultry Vaccines Market Breakdown by End User
13.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.4.1 Overview
13.4.4.4.2 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Type
13.4.4.4.3 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Technology
13.4.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.4.5 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Disease
13.4.4.4.6 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.4.7 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by End User
13.5 South and Central America
13.5.1 South and Central America Poultry Vaccines Market Overview
13.5.2 South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.3 Poultry Vaccines Market Breakdown by Countries
13.5.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.5.4.1 Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.1.1 Overview
13.5.4.1.2 Brazil: Poultry Vaccines Market Breakdown by Type
13.5.4.1.3 Brazil: Poultry Vaccines Market Breakdown by Technology
13.5.4.1.4 Brazil: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.1.5 Brazil: Poultry Vaccines Market Breakdown by Disease
13.5.4.1.6 Brazil: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.1.7 Brazil: Poultry Vaccines Market Breakdown by End User
13.5.4.2 Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.2.1 Overview
13.5.4.2.2 Argentina: Poultry Vaccines Market Breakdown by Type
13.5.4.2.3 Argentina: Poultry Vaccines Market Breakdown by Technology
13.5.4.2.4 Argentina: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.2.5 Argentina: Poultry Vaccines Market Breakdown by Disease
13.5.4.2.6 Argentina: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.2.7 Argentina: Poultry Vaccines Market Breakdown by End User
13.5.4.3 Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.3.1 Overview
13.5.4.3.2 Rest of South and Central America: Poultry Vaccines Market Breakdown by Type
13.5.4.3.3 Rest of South and Central America: Poultry Vaccines Market Breakdown by Technology
13.5.4.3.4 Rest of South and Central America: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.3.5 Rest of South and Central America: Poultry Vaccines Market Breakdown by Disease
13.5.4.3.6 Rest of South and Central America: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.3.7 Rest of South and Central America: Poultry Vaccines Market Breakdown by End User
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Global Poultry Vaccines Market
14.3 Organic Developments
14.3.1 Overview
14.1 Inorganic Developments
14.1.1 Overview
15. COMPANY PROFILES
15.1 Boehringer Ingelheim International GmbH
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Zoetis Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 BIOVAC
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Phibro Animal Health Corp
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Hester Biosciences Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Venky's (India) Ltd
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Dechra Pharmaceuticals PLC
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Elanco Animal Health Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Merck KGaA
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Ceva
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Nisseiken Co Ltd
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Vaccinova AB
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
4. POULTRY VACCINES MARKET LANDSCAPE
4.1 PEST Analysis
5. POULTRY VACCINES MARKET – KEY MARKET DYNAMICS
5.1 Poultry Vaccines Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Poultry Diseases
5.2.2 Growing Poultry Industry
5.3 Market Restraints
5.3.1 Vaccination Failure and Improper Handling
5.4 Market Opportunities
5.4.1 Government Support for Mass Vaccination Drives and Innovative Schemes
5.5 Future Trends
5.5.1 Advancements in Vectored and Combination Vaccines
5.6 Impact of Drivers and Restraints:
6. POULTRY VACCINES MARKET ANALYSIS
6.1 Poultry Vaccines Market Revenue (US$ Million), 2023–2031
7. POULTRY VACCINES MARKET ANALYSIS – BY TYPE
7.1 Overview
7.2 Broiler
7.2.1 Overview
7.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Layer
7.3.1 Overview
7.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. POULTRY VACCINES MARKET ANALYSIS – BY TECHNOLOGY
8.1 Overview
8.2 Live Attenuated Vaccines
8.2.1 Overview
8.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Inactivated Vaccines
8.3.1 Overview
8.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Recombinant Vaccines
8.4.1 Overview
8.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. POULTRY VACCINES MARKET ANALYSIS – BY DOSAGE FORM
9.1 Overview
9.2 Liquid Vaccines
9.2.1 Overview
9.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Freeze-Dried Vaccines
9.3.1 Overview
9.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Dust/Powdered Vaccines
9.4.1 Overview
9.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. POULTRY VACCINES MARKET ANALYSIS – BY DISEASE
10.1 Overview
10.2 Avian Influenza
10.2.1 Overview
10.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Salmonellosis
10.3.1 Overview
10.3.2 Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Mareks Disease
10.4.1 Overview
10.4.2 Mareks Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Infectious Bronchitis (IB)
10.5.1 Overview
10.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Infectious Bursal Disease (IBD)
10.6.1 Overview
10.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.7 Newcastle Disease
10.7.1 Overview
10.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.8 Others
10.8.1 Overview
10.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. POULTRY VACCINES MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
11.1 Overview
11.2 Drinking Water (D/W)
11.2.1 Overview
11.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Intramuscular (I/M)
11.3.1 Overview
11.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Subcutaneous (S/C)
11.4.1 Overview
11.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. POULTRY VACCINES MARKET ANALYSIS – BY END USER
12.1 Overview
12.2 Poultry Farms
12.2.1 Overview
12.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.3 Veterinary Hospitals
12.3.1 Overview
12.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.4 Poultry Vaccination Centers and Clinics
12.4.1 Overview
12.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13. POULTRY VACCINES MARKET – GEOGRAPHICAL ANALYSIS
13.1 North America
13.1.1 North America Poultry Vaccines Market Overview
13.1.2 North America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.1.3.1 United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.1.1 Overview
13.1.3.1.2 United States: Poultry Vaccines Market Breakdown by Type
13.1.3.1.3 United States: Poultry Vaccines Market Breakdown by Technology
13.1.3.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.1.5 United States: Poultry Vaccines Market Breakdown by Disease
13.1.3.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.1.7 United States: Poultry Vaccines Market Breakdown by End User
13.1.3.2 Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.2.1 Overview
13.1.3.2.2 Canada: Poultry Vaccines Market Breakdown by Type
13.1.3.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
13.1.3.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
13.1.3.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.2.7 Canada: Poultry Vaccines Market Breakdown by End User
13.1.3.3 Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.1.3.3.1 Overview
13.1.3.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
13.1.3.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
13.1.3.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
13.1.3.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
13.1.3.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
13.1.3.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
13.2 Europe
13.2.1 Europe Poultry Vaccine Market Overview
13.2.2 Europe: Poultry Vaccine Market – Revenue and Forecast to 2031 (US$ Million)
13.2.3 Poultry Vaccines Market Breakdown by Countries
13.2.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.2.4.1 Germany: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.1.1 Overview
13.2.4.1.2 Germany: Poultry Vaccines Market Breakdown by Type
13.2.4.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
13.2.4.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
13.2.4.1.6 Germany: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.1.7 Germany: Poultry Vaccines Market Breakdown by End User
13.2.4.2 Spain: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.2.1 Overview
13.2.4.2.2 Spain: Poultry Vaccines Market Breakdown by Type
13.2.4.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
13.2.4.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
13.2.4.2.6 Spain: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.2.7 Spain: Poultry Vaccines Market Breakdown by End User
13.2.4.3 France: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.3.1 Overview
13.2.4.3.2 France: Poultry Vaccines Market Breakdown by Type
13.2.4.3.3 France: Poultry Vaccines Market Breakdown by Technology
13.2.4.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.3.5 France: Poultry Vaccines Market Breakdown by Disease
13.2.4.3.6 France: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.3.7 France: Poultry Vaccines Market Breakdown by End User
13.2.4.4 United Kingdom: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.4.1 Overview
13.2.4.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
13.2.4.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
13.2.4.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
13.2.4.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
13.2.4.5 Italy: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.5.1 Overview
13.2.4.5.2 Italy: Poultry Vaccines Market Breakdown by Type
13.2.4.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
13.2.4.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
13.2.4.5.6 Italy: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.5.7 Italy: Poultry Vaccines Market Breakdown by End User
13.2.4.6 Rest of Europe: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.2.4.6.1 Overview
13.2.4.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
13.2.4.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
13.2.4.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
13.2.4.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
13.2.4.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route Of Administration
13.2.4.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User
13.3 Asia Pacific
13.3.1 Asia Pacific Poultry Vaccines Market Overview
13.3.2 Asia Pacific: Poultry Vaccines Market
13.3.3 Poultry Vaccines Market Breakdown by Countries
13.3.3.1 China: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.1.1 Overview
13.3.3.1.2 China: Poultry Vaccines Market Breakdown by Type
13.3.3.1.3 China: Poultry Vaccines Market Breakdown by Technology
13.3.3.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.1.5 China: Poultry Vaccines Market Breakdown by Disease
13.3.3.1.6 China: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.1.7 China: Poultry Vaccines Market Breakdown by End User
13.3.3.2 India: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.2.1 Overview
13.3.3.2.2 India: Poultry Vaccines Market Breakdown by Type
13.3.3.2.3 India: Poultry Vaccines Market Breakdown by Technology
13.3.3.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.2.5 India: Poultry Vaccines Market Breakdown by Disease
13.3.3.2.6 India: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.2.7 India: Poultry Vaccines Market Breakdown by End User
13.3.3.3 Japan: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.3.1 Overview
13.3.3.3.2 Japan: Poultry Vaccines Market Breakdown by Type
13.3.3.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
13.3.3.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
13.3.3.3.6 Japan: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.3.7 Japan: Poultry Vaccines Market Breakdown by End User
13.3.3.4 Australia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.4.1 Overview
13.3.3.4.2 Australia: Poultry Vaccines Market Breakdown by Type
13.3.3.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
13.3.3.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
13.3.3.4.6 Australia: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.4.7 Australia: Poultry Vaccines Market Breakdown by End User
13.3.3.5 South Korea: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.5.1 Overview
13.3.3.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
13.3.3.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
13.3.3.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
13.3.3.5.6 South Korea: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
13.3.3.6 Rest of APAC: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.3.3.6.1 Overview
13.3.3.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
13.3.3.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
13.3.3.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
13.3.3.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
13.3.3.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route Of Administration
13.3.3.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User
13.4 Middle East and Africa
13.4.1 Middle East and Africa Poultry Vaccines Market Overview
13.4.2 Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.3 Poultry Vaccines Market Breakdown by Countries
13.4.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.4.4.1 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.1.1 Overview
13.4.4.1.2 The table below represents the H5N8 Avian Influenza (HPAI) outbreak from June 2017 to November 2020:
13.4.4.1.3 South Africa: Poultry Vaccines Market Breakdown by Type
13.4.4.1.4 South Africa: Poultry Vaccines Market Breakdown by Technology
13.4.4.1.5 South Africa: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.1.6 South Africa: Poultry Vaccines Market Breakdown by Disease
13.4.4.1.7 South Africa: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.1.8 South Africa: Poultry Vaccines Market Breakdown by End User
13.4.4.2 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.2.1 Overview
13.4.4.2.2 Saudi Arabia: Poultry Vaccines Market Breakdown by Type
13.4.4.2.3 Saudi Arabia: Poultry Vaccines Market Breakdown by Technology
13.4.4.2.4 Saudi Arabia: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.2.5 Saudi Arabia: Poultry Vaccines Market Breakdown by Disease
13.4.4.2.6 Saudi Arabia: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.2.7 Saudi Arabia: Poultry Vaccines Market Breakdown by End User
13.4.4.3 United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.3.1 Overview
13.4.4.3.2 United Arab Emirates: Poultry Vaccines Market Breakdown by Type
13.4.4.3.3 United Arab Emirates: Poultry Vaccines Market Breakdown by Technology
13.4.4.3.4 United Arab Emirates: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.3.5 United Arab Emirates: Poultry Vaccines Market Breakdown by Disease
13.4.4.3.6 United Arab Emirates: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.3.7 United Arab Emirates: Poultry Vaccines Market Breakdown by End User
13.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.4.4.4.1 Overview
13.4.4.4.2 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Type
13.4.4.4.3 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Technology
13.4.4.4.4 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Dosage Form
13.4.4.4.5 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Disease
13.4.4.4.6 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by Route Of Administration
13.4.4.4.7 Rest of Middle East and Africa: Poultry Vaccines Market Breakdown by End User
13.5 South and Central America
13.5.1 South and Central America Poultry Vaccines Market Overview
13.5.2 South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.3 Poultry Vaccines Market Breakdown by Countries
13.5.4 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
13.5.4.1 Brazil: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.1.1 Overview
13.5.4.1.2 Brazil: Poultry Vaccines Market Breakdown by Type
13.5.4.1.3 Brazil: Poultry Vaccines Market Breakdown by Technology
13.5.4.1.4 Brazil: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.1.5 Brazil: Poultry Vaccines Market Breakdown by Disease
13.5.4.1.6 Brazil: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.1.7 Brazil: Poultry Vaccines Market Breakdown by End User
13.5.4.2 Argentina: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.2.1 Overview
13.5.4.2.2 Argentina: Poultry Vaccines Market Breakdown by Type
13.5.4.2.3 Argentina: Poultry Vaccines Market Breakdown by Technology
13.5.4.2.4 Argentina: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.2.5 Argentina: Poultry Vaccines Market Breakdown by Disease
13.5.4.2.6 Argentina: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.2.7 Argentina: Poultry Vaccines Market Breakdown by End User
13.5.4.3 Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
13.5.4.3.1 Overview
13.5.4.3.2 Rest of South and Central America: Poultry Vaccines Market Breakdown by Type
13.5.4.3.3 Rest of South and Central America: Poultry Vaccines Market Breakdown by Technology
13.5.4.3.4 Rest of South and Central America: Poultry Vaccines Market Breakdown by Dosage Form
13.5.4.3.5 Rest of South and Central America: Poultry Vaccines Market Breakdown by Disease
13.5.4.3.6 Rest of South and Central America: Poultry Vaccines Market Breakdown by Route Of Administration
13.5.4.3.7 Rest of South and Central America: Poultry Vaccines Market Breakdown by End User
14. INDUSTRY LANDSCAPE
14.1 Overview
14.2 Growth Strategies in the Global Poultry Vaccines Market
14.3 Organic Developments
14.3.1 Overview
14.1 Inorganic Developments
14.1.1 Overview
15. COMPANY PROFILES
15.1 Boehringer Ingelheim International GmbH
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 Zoetis Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 BIOVAC
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Phibro Animal Health Corp
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Hester Biosciences Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Venky's (India) Ltd
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Dechra Pharmaceuticals PLC
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Elanco Animal Health Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Merck KGaA
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Ceva
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Nisseiken Co Ltd
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Vaccinova AB
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
16.2 Glossary of Terms
